Brainsway Ltd - ADR
NASDAQ:BWAY 4:00:00 PM EDT
| Market Cap (Intraday) | 124.59M |
| Current PE | 204.91 |
| Forward PE | 149.4 |
| 2yr Forward PE | 67.91 |
| 10-Day MA | $7.52 |
| 50-Day MA | $7.14 |
| 200-Day MA | $6.28 |
Brainsway Ltd - ADR Stock, NASDAQ:BWAY
Bynet Building, 19 Hartum Street, 3rd Floor, Jerusalem, Jerusalem 9777518
Israel
Phone: +972.2.582.4030
Number of Employees: 106
Description
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.